% alzhub.org library filter
% Source: https://alzhub.org/research?institution=I168537998
% 118 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{zimmer2025-40063015,
  author  = {Zimmer, J. A. and Ardayfio, P. and Wang, H. and Khanna, R. and Evans, C. D. and Lu, M. and Sparks, J. and Andersen, S. and Lauzon, S. and Nery, E. S. M. and others},
  title   = {{Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease: Secondary Analysis of the TRAILBLAZER-ALZ and ALZ 2 Randomized Clinical Trials}},
  journal = {JAMA Neurology},
  year    = {2025},
  doi     = {10.1001/jamaneurol.2025.0065},
  pmid    = {40063015},
  url     = {https://doi.org/10.1001/jamaneurol.2025.0065}
}

@article{pontecorvo2022-36251300,
  author  = {Pontecorvo, M. J. and Lu, M. and Burnham, S. C. and Schade, A. E. and Dage, J. L. and Shcherbinin, S. and Collins, E. C. and Sims, JR. and others},
  title   = {{Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2022.3392},
  pmid    = {36251300},
  url     = {https://doi.org/10.1001/jamaneurol.2022.3392}
}

@article{honig2018-29365294,
  author  = {Honig, L. S. and Vellas, B. and Woodward, M. and Boada, M. and Bullock, R. and Borrie, M. and Hager, K. and Andreasen, N. and others},
  title   = {{Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease}},
  journal = {The New England journal of medicine},
  year    = {2018},
  doi     = {10.1056/nejmoa1705971},
  pmid    = {29365294},
  url     = {https://doi.org/10.1056/nejmoa1705971}
}

@article{blazhenets2026-42441390,
  author  = {Blazhenets, Ganna and Soleimani-Meigooni, David N and Chiotis, Konstantinos and Allen, Isabel E and Rabinovici, Gil D and La Joie, Renaud and {Meta-Centiloid Study Group} and Apostolova, Liana G and others},
  title   = {{Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis}},
  journal = {JAMA},
  year    = {2026},
  doi     = {10.1001/jama.2026.13116},
  pmid    = {42441390},
  url     = {https://doi.org/10.1001/jama.2026.13116}
}

@article{mintun2021-33720637,
  author  = {Mintun, M. A. and Lo, A. C. and Duggan Evans, C. and Wessels, A. M. and Ardayfio, P. A. and Andersen, S. W. and Shcherbinin, S. and Sparks, J. and others},
  title   = {{Donanemab in Early Alzheimer's Disease}},
  journal = {The New England journal of medicine},
  year    = {2021},
  doi     = {10.1056/nejmoa2100708},
  pmid    = {33720637},
  url     = {https://doi.org/10.1056/nejmoa2100708}
}

@article{wessels2020-31764959,
  author  = {Wessels, A. M. and Tariot, P. N. and Zimmer, J. A. and Selzler, K. J. and Bragg, S. M. and Andersen, S. W. and Landry, J. and Krull, J. H. and others},
  title   = {{Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials}},
  journal = {JAMA neurology},
  year    = {2020},
  doi     = {10.1001/jamaneurol.2019.3988},
  pmid    = {31764959},
  url     = {https://doi.org/10.1001/jamaneurol.2019.3988}
}

@article{palmqvist2020-32722745,
  author  = {Palmqvist, S. and Janelidze, S. and Quiroz, Y. T. and Zetterberg, H. and Lopera, F. and Stomrud, E. and Su, Y. and Chen, Y. and others},
  title   = {{Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders}},
  journal = {JAMA},
  year    = {2020},
  doi     = {10.1001/jama.2020.12134},
  pmid    = {32722745},
  url     = {https://doi.org/10.1001/jama.2020.12134}
}

@article{yaffe2004-15326238,
  author  = {Yaffe, K. and Blackwell, T. and Kanaya, A. M. and Davidowitz, N. and Barrett-Connor, E. and Krueger, K.},
  title   = {{Diabetes, impaired fasting glucose, and development of cognitive impairment in older women}},
  journal = {Neurology},
  year    = {2004},
  doi     = {10.1212/01.wnl.0000134666.64593.ba},
  pmid    = {15326238},
  url     = {https://doi.org/10.1212/01.wnl.0000134666.64593.ba}
}

@article{wang2025-40172303,
  author  = {Wang, H. and Serap Monkul Nery, E. and Ardayfio, P. and Khanna, R. and Otero Svaldi, D. and Gueorguieva, I. and Shcherbinin, S. and Andersen, S. W. and Hauck, P. M. and Engle, S. E. and others},
  title   = {{Modified titration of donanemab reduces ARIA risk and maintains amyloid reduction}},
  journal = {Alzheimer's \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz.70062},
  pmid    = {40172303},
  url     = {https://doi.org/10.1002/alz.70062}
}

@article{lu2025-41082199,
  author  = {Lu, M. and Kim, M. J. and Collins, E. C. and Shcherbinin, S. and Ellinwood, A. K. and Yokoi, Y. and Brooks, D. A. and Hansson, O. and others},
  title   = {{Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ 2 Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2025},
  doi     = {10.1001/jamaneurol.2025.3869},
  pmid    = {41082199},
  url     = {https://doi.org/10.1001/jamaneurol.2025.3869}
}

@article{shcherbinin2022-36094645,
  author  = {Shcherbinin, S. and Evans, C. D. and Lu, M. and Andersen, S. W. and Pontecorvo, M. J. and Willis, B. A. and Gueorguieva, I. and Hauck, P. M. and others},
  title   = {{Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes: The TRAILBLAZER-ALZ Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2022.2793},
  pmid    = {36094645},
  url     = {https://doi.org/10.1001/jamaneurol.2022.2793}
}

@article{moscoso2025-40522652,
  author  = {Moscoso, Alexis and Heeman, Fiona and Raghavan, Sheelakumari and Costoya‐Sánchez, Alejandro and van Essen, Martijn and Mainta, Ismini and Camacho, Valle and Rodríguez-Fonseca, Omar Darío and others},
  title   = {{Frequency and Clinical Outcomes Associated With Tau Positron Emission Tomography Positivity}},
  journal = {JAMA},
  year    = {2025},
  doi     = {10.1001/jama.2025.7817},
  pmid    = {40522652},
  url     = {https://doi.org/10.1001/jama.2025.7817}
}

@article{janelidze2021-33165506,
  author  = {Janelidze, S. and Berron, D. and Smith, R. and Strandberg, O. and Proctor, N. K. and Dage, J. L. and Stomrud, E. and Palmqvist, S. and others},
  title   = {{Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease}},
  journal = {JAMA neurology},
  year    = {2021},
  doi     = {10.1001/jamaneurol.2020.4201},
  pmid    = {33165506},
  url     = {https://doi.org/10.1001/jamaneurol.2020.4201}
}

@article{janelidze2020-32123385,
  author  = {Janelidze, S. and Mattsson, N. and Palmqvist, S. and Smith, R. and Beach, T. G. and Serrano, G. E. and Chai, X. and Proctor, N. K. and others},
  title   = {{Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia}},
  journal = {Nature medicine},
  year    = {2020},
  doi     = {10.1038/s41591-020-0755-1},
  pmid    = {32123385},
  url     = {https://doi.org/10.1038/s41591-020-0755-1}
}

@article{janelidze2020-32246036,
  author  = {Janelidze, S. and Stomrud, E. and Smith, R. and Palmqvist, S. and Mattsson, N. and Airey, D. C. and Proctor, N. K. and Chai, X. and others},
  title   = {{Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease}},
  journal = {Nature communications},
  year    = {2020},
  doi     = {10.1038/s41467-020-15436-0},
  pmid    = {32246036},
  url     = {https://doi.org/10.1038/s41467-020-15436-0}
}

@article{mattssoncarlgren2020-33068398,
  author  = {Mattsson-Carlgren, N. and Janelidze, S. and Palmqvist, S. and Cullen, N. and Svenningsson, A. L. and Strandberg, O. and Mengel, D. and Walsh, D. M. and others},
  title   = {{Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease}},
  journal = {Brain : a journal of neurology},
  year    = {2020},
  doi     = {10.1093/brain/awaa286},
  pmid    = {33068398},
  url     = {https://doi.org/10.1093/brain/awaa286}
}

@article{wagemann2024-38683602,
  author  = {Wagemann, O. and Liu, H. and Wang, G. and Shi, X. and Bittner, T. and Scelsi, M. A. and Farlow, M. R. and Clifford, D. B. and others},
  title   = {{Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2024},
  doi     = {10.1001/jamaneurol.2024.0991},
  pmid    = {38683602},
  url     = {https://doi.org/10.1001/jamaneurol.2024.0991}
}

@article{sims2023-37459141,
  author  = {Sims, JR. and Zimmer, J. A. and Evans, C. D. and Lu, M. and Ardayfio, P. and Sparks, J. and Wessels, A. M. and Shcherbinin, S. and others},
  title   = {{Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial}},
  journal = {JAMA},
  year    = {2023},
  doi     = {10.1001/jama.2023.13239},
  pmid    = {37459141},
  url     = {https://doi.org/10.1001/jama.2023.13239}
}

@article{bodick1997-9109749,
  author  = {Bodick, N. C. and Offen, W. W. and Levey, A. I. and Cutler, N. R. and Gauthier, S. G. and Satlin, A. and Shannon, H. E. and Tollefson, G. D. and others},
  title   = {{Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease}},
  journal = {Archives of neurology},
  year    = {1997},
  doi     = {10.1001/archneur.1997.00550160091022},
  pmid    = {9109749},
  url     = {https://doi.org/10.1001/archneur.1997.00550160091022}
}

@article{fleisher2024-38386949,
  author  = {Fleisher, A. S. and Munsie, L. M. and Perahia, D. G. S. and Andersen, S. W. and Higgins, I. A. and Hauck, P. M. and Lo, A. C. and Sims, JR. and others},
  title   = {{Assessment of Efficacy and Safety of Zagotenemab: Results From PERISCOPE-ALZ, a Phase 2 Study in Early Symptomatic Alzheimer Disease}},
  journal = {Neurology},
  year    = {2024},
  doi     = {10.1212/wnl.0000000000208061},
  pmid    = {38386949},
  url     = {https://doi.org/10.1212/wnl.0000000000208061}
}

@article{galasko2012-22431837,
  author  = {Galasko, D. R. and Peskind, E. and Clark, C. M. and Quinn, J. F. and Ringman, J. M. and Jicha, G. A. and Cotman, C. and Cottrell, B. and others},
  title   = {{Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures}},
  journal = {Archives of neurology},
  year    = {2012},
  doi     = {10.1001/archneurol.2012.85},
  pmid    = {22431837},
  url     = {https://doi.org/10.1001/archneurol.2012.85}
}

@article{janelidze2023-36087307,
  author  = {Janelidze, S. and Bali, D. and Ashton, N. J. and Barthélemy, N. R. and Vanbrabant, J. and Stoops, E. and Vanmechelen, E. and others},
  title   = {{Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease}},
  journal = {Brain : a journal of neurology},
  year    = {2023},
  doi     = {10.1093/brain/awac333},
  pmid    = {36087307},
  url     = {https://doi.org/10.1093/brain/awac333}
}

@article{pontecorvo2019-31009046,
  author  = {Pontecorvo, M. J. and Devous, M. D. and Kennedy, I. and Navitsky, M. and Lu, M. and Galante, N. and Salloway, S. and Doraiswamy, P. M. and others},
  title   = {{A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia}},
  journal = {Brain : a journal of neurology},
  year    = {2019},
  doi     = {10.1093/brain/awz090},
  pmid    = {31009046},
  url     = {https://doi.org/10.1093/brain/awz090}
}

@article{siemers2006-16505324,
  author  = {Siemers, E. R. and Quinn, J. F. and Kaye, J. and Farlow, M. R. and Porsteinsson, A. and Tariot, P. and Zoulnouni, P. and Galvin, J. E. and others},
  title   = {{Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer disease}},
  journal = {Neurology},
  year    = {2006},
  doi     = {10.1212/01.wnl.0000198762.41312.e1},
  pmid    = {16505324},
  url     = {https://doi.org/10.1212/01.wnl.0000198762.41312.e1}
}

@article{palmqvist2021-34031605,
  author  = {Palmqvist, S. and Tideman, P. and Cullen, N. and Zetterberg, H. and Blennow, K. and {Alzheimer’s Disease Neuroimaging Initiative} and Dage, J. L. and Stomrud, E. and others},
  title   = {{Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures}},
  journal = {Nature medicine},
  year    = {2021},
  doi     = {10.1038/s41591-021-01348-z},
  pmid    = {34031605},
  url     = {https://doi.org/10.1038/s41591-021-01348-z}
}

@article{jansen2022-35099509,
  author  = {Jansen, W. J. and Janssen, O. and Tijms, B. M. and Vos, S. J. B. and Ossenkoppele, R. and Visser, P. J. and {Amyloid Biomarker Study Group} and Aarsland, D. and others},
  title   = {{Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2021.5216},
  pmid    = {35099509},
  url     = {https://doi.org/10.1001/jamaneurol.2021.5216}
}

@article{sperling2011-21514248,
  author  = {Sperling, R. A. and Aisen, P. S. and Beckett, L. A. and Bennett, D. A. and Craft, S. and Fagan, A. M. and Iwatsubo, T. and Jack, C. R. and others},
  title   = {{Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2011},
  doi     = {10.1016/j.jalz.2011.03.003},
  pmid    = {21514248},
  url     = {https://doi.org/10.1016/j.jalz.2011.03.003}
}

@article{fleisher2008-18695053,
  author  = {Fleisher, A. S. and Raman, R. and Siemers, E. R. and Becerra, L. and Clark, C. M. and Dean, R. A. and Farlow, M. R. and Galvin, J. E. and others},
  title   = {{Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease}},
  journal = {Archives of neurology},
  year    = {2008},
  doi     = {10.1001/archneur.65.8.1031},
  pmid    = {18695053},
  url     = {https://doi.org/10.1001/archneur.65.8.1031}
}

@article{costoyasanchez2023-37578787,
  author  = {Costoya-Sánchez, A. and Moscoso, A. and Silva-Rodríguez, J. and Pontecorvo, M. J. and Devous, M. D. and Aguiar, P. and Schöll, M. and Grothe, M. J. and others},
  title   = {{Increased Medial Temporal Tau Positron Emission Tomography Uptake in the Absence of Amyloid-β Positivity}},
  journal = {JAMA neurology},
  year    = {2023},
  doi     = {10.1001/jamaneurol.2023.2560},
  pmid    = {37578787},
  url     = {https://doi.org/10.1001/jamaneurol.2023.2560}
}

@article{weiner2015-26073027,
  author  = {Weiner, M. W. and Veitch, D. P. and Aisen, P. S. and Beckett, L. A. and Cairns, N. J. and Cedarbaum, J. and Green, R. C. and Harvey, D. and others},
  title   = {{2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2015},
  doi     = {10.1016/j.jalz.2014.11.001},
  pmid    = {26073027},
  url     = {https://doi.org/10.1016/j.jalz.2014.11.001}
}

@article{sperling2020-32250387,
  author  = {Sperling, R. A. and Donohue, M. C. and Raman, R. and Sun, C. K. and Yaari, R. and Holdridge, K. and Siemers, E. and Johnson, K. A. and others},
  title   = {{Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals}},
  journal = {JAMA neurology},
  year    = {2020},
  doi     = {10.1001/jamaneurol.2020.0387},
  pmid    = {32250387},
  url     = {https://doi.org/10.1001/jamaneurol.2020.0387}
}

@article{ayton2015-25988319,
  author  = {Ayton, S. and Faux, N. G. and Bush, A. I. and {Alzheimer's Disease Neuroimaging Initiative}},
  title   = {{Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE}},
  journal = {Nature communications},
  year    = {2015},
  doi     = {10.1038/ncomms7760},
  pmid    = {25988319},
  url     = {https://doi.org/10.1038/ncomms7760}
}

@article{young2018-30323170,
  author  = {Young, A. L. and Marinescu, R. V. and Oxtoby, N. P. and Bocchetta, M. and Yong, K. and Firth, N. C. and Cash, D. M. and Thomas, D. L. and others},
  title   = {{Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference}},
  journal = {Nature communications},
  year    = {2018},
  doi     = {10.1038/s41467-018-05892-0},
  pmid    = {30323170},
  url     = {https://doi.org/10.1038/s41467-018-05892-0}
}

@article{cullen2021-37117993,
  author  = {Cullen, N. C. and Leuzy, A. and Palmqvist, S. and Janelidze, S. and Stomrud, E. and Pesini, P. and Sarasa, L. and Allué, J. A. and others},
  title   = {{Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations}},
  journal = {Nature aging},
  year    = {2021},
  doi     = {10.1038/s43587-020-00003-5},
  pmid    = {37117993},
  url     = {https://doi.org/10.1038/s43587-020-00003-5}
}

@article{shaw2009-19296504,
  author  = {Shaw, Leslie M. and Vanderstichele, Hugo and Knapik-Czajka, Malgorzata Elzbieta and Clark, Christopher M. and Aisen, Paul S. S. and Petersen, Ronald Carl and Blennow, Kaj and Soares, Holly D and others},
  title   = {{Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects}},
  journal = {Annals of Neurology},
  year    = {2009},
  doi     = {10.1002/ana.21610},
  pmid    = {19296504},
  url     = {https://doi.org/10.1002/ana.21610}
}

@article{street2000-11015815,
  author  = {Street, J. S. and Clark, W. S. and Gannon, K. S. and Cummings, J. L. and Bymaster, F. P. and Tamura, R. N. and Mitan, S. J. and Kadam, D. L. and others},
  title   = {{Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group}},
  journal = {Archives of general psychiatry},
  year    = {2000},
  doi     = {10.1001/archpsyc.57.10.968},
  pmid    = {11015815},
  url     = {https://doi.org/10.1001/archpsyc.57.10.968}
}

@article{chappell2007-17389305,
  author  = {Chappell, A. S. and Gonzales, C. and Williams, J. and Witte, M. M. and Mohs, R. C. and Sperling, R.},
  title   = {{AMPA potentiator treatment of cognitive deficits in Alzheimer disease}},
  journal = {Neurology},
  year    = {2007},
  doi     = {10.1212/01.wnl.0000260240.46070.7c},
  pmid    = {17389305},
  url     = {https://doi.org/10.1212/01.wnl.0000260240.46070.7c}
}

@article{leuzy2023-37155176,
  author  = {Leuzy, A. and Binette, A. P. and Vogel, J. W. and Klein, G. and Borroni, E. and Tonietto, M. and Strandberg, O. and Mattsson-Carlgren, N. and others},
  title   = {{Comparison of Group-Level and Individualized Brain Regions for Measuring Change in Longitudinal Tau Positron Emission Tomography in Alzheimer Disease}},
  journal = {JAMA neurology},
  year    = {2023},
  doi     = {10.1001/jamaneurol.2023.1067},
  pmid    = {37155176},
  url     = {https://doi.org/10.1001/jamaneurol.2023.1067}
}

@article{mielke2021-34309632,
  author  = {Mielke, M. M. and Frank, R. D. and Dage, J. L. and Jeromin, A. and Ashton, N. J. and Blennow, K. and Karikari, T. K. and Vanmechelen, E. and others},
  title   = {{Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes}},
  journal = {JAMA neurology},
  year    = {2021},
  doi     = {10.1001/jamaneurol.2021.2293},
  pmid    = {34309632},
  url     = {https://doi.org/10.1001/jamaneurol.2021.2293}
}

@article{josephmathurin2022-36151869,
  author  = {Joseph-Mathurin, N. and Llibre-Guerra, J. J. and Li, Y. and McCullough, A. A. and Hofmann, C. and Wojtowicz, J. and Park, E. and Wang, G. and others},
  title   = {{Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease}},
  journal = {Annals of neurology},
  year    = {2022},
  doi     = {10.1002/ana.26511},
  pmid    = {36151869},
  url     = {https://doi.org/10.1002/ana.26511}
}

@article{thijssen2021-34418401,
  author  = {Thijssen, E. H. and La Joie, R. and Strom, A. and Fonseca, C. and Iaccarino, L. and Wolf, A. and Spina, S. and Allen, I. E. and others},
  title   = {{Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study}},
  journal = {The Lancet. Neurology},
  year    = {2021},
  doi     = {10.1016/s1474-4422(21)00214-3},
  pmid    = {34418401},
  url     = {https://doi.org/10.1016/s1474-4422(21)00214-3}
}

@article{trzepacz2015-26346644,
  author  = {Trzepacz, P. T. and Hochstetler, H. and Wang, S. and Walker, B. and Saykin, A. J. and {Alzheimer’s Disease Neuroimaging Initiative}},
  title   = {{Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults}},
  journal = {BMC geriatrics},
  year    = {2015},
  doi     = {10.1186/s12877-015-0103-3},
  pmid    = {26346644},
  url     = {https://doi.org/10.1186/s12877-015-0103-3}
}

@article{mielke2017-28692710,
  author  = {Mielke, M. M. and Hagen, C. E. and Wennberg, A. M. V. and Airey, D. C. and Savica, R. and Knopman, D. S. and Machulda, M. M. and Roberts, R. O. and others},
  title   = {{Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging}},
  journal = {JAMA neurology},
  year    = {2017},
  doi     = {10.1001/jamaneurol.2017.1359},
  pmid    = {28692710},
  url     = {https://doi.org/10.1001/jamaneurol.2017.1359}
}

@article{fleisher2026-42441396,
  author  = {Fleisher, Adam S and Munsie, Leanne and Mancini, Michele and Cheng, Yun-Ju and Guo, Jiaying and Nuthall, Hugh and Otero, Diana Svaldi and Kotari, Vikas and others},
  title   = {{Ceperognastat in Early Symptomatic Alzheimer Disease: A Randomized Clinical Trial}},
  journal = {JAMA},
  year    = {2026},
  doi     = {10.1001/jama.2026.12768},
  pmid    = {42441396},
  url     = {https://doi.org/10.1001/jama.2026.12768}
}

@article{steward2023-37930695,
  author  = {Steward, A. and Biel, D. and Dewenter, A. and Roemer, S. and Wagner, F. and Dehsarvi, A. and Rathore, S. and Otero Svaldi, D. and others},
  title   = {{ApoE4 and Connectivity-Mediated Spreading of Tau Pathology at Lower Amyloid Levels}},
  journal = {JAMA neurology},
  year    = {2023},
  doi     = {10.1001/jamaneurol.2023.4038},
  pmid    = {37930695},
  url     = {https://doi.org/10.1001/jamaneurol.2023.4038}
}

@article{jack2018-29653606,
  author  = {Jack, C. R. and Bennett, D. A. and Blennow, K. and Carrillo, M. C. and Dunn, B. and Haeberlein, S. B. and Holtzman, D. M. and Jagust, W. and others},
  title   = {{NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2018},
  doi     = {10.1016/j.jalz.2018.02.018},
  pmid    = {29653606},
  url     = {https://doi.org/10.1016/j.jalz.2018.02.018}
}

@article{jiang2020-32273329,
  author  = {Jiang, C. and Hopfner, F. and Katsikoudi, A. and Hein, R. and Catli, C. and Evetts, S. and Huang, Y. and others},
  title   = {{Serum neuronal exosomes predict and differentiate Parkinson's disease from atypical parkinsonism}},
  journal = {Journal of neurology, neurosurgery, and psychiatry},
  year    = {2020},
  doi     = {10.1136/jnnp-2019-322588},
  pmid    = {32273329},
  url     = {https://doi.org/10.1136/jnnp-2019-322588}
}

@article{thijssen2020-32123386,
  author  = {Thijssen, E. H. and La Joie, R. and Wolf, A. and Strom, A. and Wang, P. and Iaccarino, L. and Bourakova, V. and Cobigo, Y. and others},
  title   = {{Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration}},
  journal = {Nature medicine},
  year    = {2020},
  doi     = {10.1038/s41591-020-0762-2},
  pmid    = {32123386},
  url     = {https://doi.org/10.1038/s41591-020-0762-2}
}

@article{milaaloma2022-35953717,
  author  = {Milà-Alomà, M. and Ashton, N. J. and Shekari, M. and Salvadó, G. and Ortiz-Romero, P. and Montoliu-Gaya, L. and Benedet, A. L. and Karikari, T. K. and others},
  title   = {{Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer's disease}},
  journal = {Nature medicine},
  year    = {2022},
  doi     = {10.1038/s41591-022-01925-w},
  pmid    = {35953717},
  url     = {https://doi.org/10.1038/s41591-022-01925-w}
}

@article{atri2026-42128444,
  author  = {Atri, A. and Apostolova, L. G. and Iwata, A. and Wessels, A. M. and Atkins, A. and Lu, M. and Ye, W. and Ryan, S. and Doty, E. G.},
  title   = {{Clinical Meaningfulness of Donanemab in Early Symptomatic Alzheimer Disease: Data From the Randomized Phase 3 TRAILBLAZER-ALZ 2 Trial}},
  journal = {Neurology: Clinical Practice},
  year    = {2026},
  doi     = {10.1212/CPJ.0000000000200621},
  pmid    = {42128444},
  url     = {https://doi.org/10.1212/CPJ.0000000000200621}
}

@article{schindler2024-38866966,
  author  = {Schindler, S. E. and Galasko, D. and Pereira, A. C. and Rabinovici, G. D. and Salloway, S. and Suárez-Calvet, M. and Khachaturian, A. S. and Mielke, M. M. and Udeh-Momoh, C. and Weiss, J. and Batrla, R. and Bozeat, S. and others},
  title   = {{Acceptable performance of blood biomarker tests of amyloid pathology - recommendations from the Global CEO Initiative on Alzheimer's Disease}},
  journal = {Nature Reviews Neurology},
  year    = {2024},
  doi     = {10.1038/s41582-024-00977-5},
  pmid    = {38866966},
  url     = {https://doi.org/10.1038/s41582-024-00977-5}
}

@article{wang2015-25728668,
  author  = {Wang, Y. and Cella, M. and Mallinson, K. and Ulrich, J. D. and Young, K. L. and Robinette, M. L. and Gilfillan, S. and Krishnan, G. M. and others},
  title   = {{TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model}},
  journal = {Cell},
  year    = {2015},
  doi     = {10.1016/j.cell.2015.01.049},
  pmid    = {25728668},
  url     = {https://doi.org/10.1016/j.cell.2015.01.049}
}

@article{jansen2018-29188296,
  author  = {Jansen, W. J. and Ossenkoppele, R. and Tijms, B. M. and Fagan, A. M. and Hansson, O. and Klunk, W. E. and van der Flier, W. M. and Villemagne, V. L. and others},
  title   = {{Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia}},
  journal = {JAMA psychiatry},
  year    = {2018},
  doi     = {10.1001/jamapsychiatry.2017.3391},
  pmid    = {29188296},
  url     = {https://doi.org/10.1001/jamapsychiatry.2017.3391}
}

@article{doody2014-24450890,
  author  = {Doody, Rachelle Smith and Thomas, Ronald G. and Farlow, Martin Rhys and Iwatsubo, Takeshi and Vellas, Bruno J. and Joffe, Steven and Kieburtz, Karl D. and Raman, Rema and Sun, Xiaoying and Aisen, Paul S. S. and Siemers, Eric and Liu‐Seifert, Hong and Mohs, Richard C.},
  title   = {{Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease}},
  journal = {New England Journal of Medicine},
  year    = {2014},
  doi     = {10.1056/nejmoa1312889},
  pmid    = {24450890},
  url     = {https://doi.org/10.1056/nejmoa1312889}
}

@article{leuzy2021-34493616,
  author  = {Leuzy, A. and Janelidze, S. and Mattsson-Carlgren, N. and Palmqvist, S. and Jacobs, D. and Cicognola, C. and Stomrud, E. and Vanmechelen, E. and others},
  title   = {{Comparing the Clinical Utility and Diagnostic Performance of CSF P-Tau181, P-Tau217, and P-Tau231 Assays}},
  journal = {Neurology},
  year    = {2021},
  doi     = {10.1212/wnl.0000000000012727},
  pmid    = {34493616},
  url     = {https://doi.org/10.1212/wnl.0000000000012727}
}

@article{mckhann2011-21514250,
  author  = {McKhann, G. M. and Knopman, D. S. and Chertkow, H. and Hyman, B. T. and Jack, C. R. and Kawas, C. H. and Klunk, W. E. and Koroshetz, W. J. and others},
  title   = {{The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2011},
  doi     = {10.1016/j.jalz.2011.03.005},
  pmid    = {21514250},
  url     = {https://doi.org/10.1016/j.jalz.2011.03.005}
}

@article{brickman2021-33580742,
  author  = {Brickman, A. M. and Manly, J. J. and Honig, L. S. and Sanchez, D. and Reyes-Dumeyer, D. and Lantigua, R. A. and Lao, P. J. and Stern, Y. and others},
  title   = {{Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community study}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2021},
  doi     = {10.1002/alz.12301},
  pmid    = {33580742},
  url     = {https://doi.org/10.1002/alz.12301}
}

@article{mattssoncarlgren2021-33949133,
  author  = {Mattsson-Carlgren, N. and Janelidze, S. and Bateman, R. J. and Smith, R. and Stomrud, E. and Serrano, G. E. and Reiman, E. M. and Palmqvist, S. and others},
  title   = {{Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau}},
  journal = {EMBO molecular medicine},
  year    = {2021},
  doi     = {10.15252/emmm.202114022},
  pmid    = {33949133},
  url     = {https://doi.org/10.15252/emmm.202114022}
}

@article{wang2016-27091843,
  author  = {Wang, Y. and Ulland, T. K. and Ulrich, J. D. and Song, W. and Tzaferis, J. A. and Hole, J. T. and Yuan, P. and Mahan, T. E. and others},
  title   = {{TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques}},
  journal = {The Journal of experimental medicine},
  year    = {2016},
  doi     = {10.1084/jem.20151948},
  pmid    = {27091843},
  url     = {https://doi.org/10.1084/jem.20151948}
}

@article{liuseifert2015-26402769,
  author  = {Liu-Seifert, H. and Siemers, E. and Price, K. and Han, B. and Selzler, K. J. and Henley, D. and Sundell, K. and Aisen, P. and others},
  title   = {{Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2015},
  doi     = {10.3233/jad-142508},
  pmid    = {26402769},
  url     = {https://doi.org/10.3233/jad-142508}
}

@article{mohs2009-19700948,
  author  = {Mohs, R. C. and Shiovitz, T. M. and Tariot, P. N. and Porsteinsson, A. P. and Baker, K. D. and Feldman, P. D.},
  title   = {{Atomoxetine augmentation of cholinesterase inhibitor therapy in patients with Alzheimer disease: 6-month, randomized, double-blind, placebo-controlled, parallel-trial study}},
  journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry},
  year    = {2009},
  doi     = {10.1097/jgp.0b013e3181aad585},
  pmid    = {19700948},
  url     = {https://doi.org/10.1097/jgp.0b013e3181aad585}
}

@article{chen2021-34537810,
  author  = {Chen, S. D. and Lu, J. Y. and Li, H. Q. and Yang, Y. X. and Jiang, J. H. and Cui, M. and Zuo, C. T. and Tan, L. and others},
  title   = {{Staging tau pathology with tau PET in Alzheimer's disease: a longitudinal study}},
  journal = {Translational psychiatry},
  year    = {2021},
  doi     = {10.1038/s41398-021-01602-5},
  pmid    = {34537810},
  url     = {https://doi.org/10.1038/s41398-021-01602-5}
}

@article{ossenkoppele2021-34254442,
  author  = {Ossenkoppele, R. and Reimand, J. and Smith, R. and Leuzy, A. and Strandberg, O. and Palmqvist, S. and Stomrud, E. and Zetterberg, H. and others},
  title   = {{Tau PET correlates with different Alzheimer's disease-related features compared to CSF and plasma p-tau biomarkers}},
  journal = {EMBO molecular medicine},
  year    = {2021},
  doi     = {10.15252/emmm.202114398},
  pmid    = {34254442},
  url     = {https://doi.org/10.15252/emmm.202114398}
}

@article{groot2022-35568889,
  author  = {Groot, C. and Cicognola, C. and Bali, D. and Triana-Baltzer, G. and Dage, J. L. and Pontecorvo, M. J. and Kolb, H. C. and Ossenkoppele, R. and others},
  title   = {{Diagnostic and prognostic performance to detect Alzheimer's disease and clinical progression of a novel assay for plasma p-tau217}},
  journal = {Alzheimer's research \& therapy},
  year    = {2022},
  doi     = {10.1186/s13195-022-01005-8},
  pmid    = {35568889},
  url     = {https://doi.org/10.1186/s13195-022-01005-8}
}

@article{games1995-7845465,
  author  = {Games, D. and Adams, D. and Alessandrini, R. and Barbour, R. and Berthelette, P. and Blackwell, C. and Carr, T. and Clemens, J. and others},
  title   = {{Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein}},
  journal = {Nature},
  year    = {1995},
  doi     = {10.1038/373523a0},
  pmid    = {7845465},
  url     = {https://doi.org/10.1038/373523a0}
}

@article{mamas2025-40980721,
  author  = {Mamas, Mamas A. and Bays, Harold Edward and Li, Runjia and Upadhyay, Navneet and Irani, Tanya and Şenyücel, Çağrı and Dunn, Julia P. and Liu‐Seifert, Hong},
  title   = {{Tirzepatide compared with semaglutide and 10-year cardiovascular disease risk reduction in obesity: post-hoc analysis of the SURMOUNT-5 trial}},
  journal = {European Heart Journal Open},
  year    = {2025},
  doi     = {10.1093/ehjopen/oeaf117},
  pmid    = {40980721},
  url     = {https://doi.org/10.1093/ehjopen/oeaf117}
}

@article{trzepacz2001-11449030,
  author  = {Trzepacz, P. T. and Mittal, D. and Torres, R. and Kanary, K. and Norton, J. and Jimerson, N.},
  title   = {{Validation of the Delirium Rating Scale-revised-98: comparison with the delirium rating scale and the cognitive test for delirium}},
  journal = {The Journal of neuropsychiatry and clinical neurosciences},
  year    = {2001},
  doi     = {10.1176/jnp.13.2.229},
  pmid    = {11449030},
  url     = {https://doi.org/10.1176/jnp.13.2.229}
}

@article{schwarz2016-26936940,
  author  = {Schwarz, A. J. and Yu, P. and Miller, B. B. and Shcherbinin, S. and Dickson, J. and Navitsky, M. and Joshi, A. D. and Devous, M. D. and others},
  title   = {{Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages}},
  journal = {Brain : a journal of neurology},
  year    = {2016},
  doi     = {10.1093/brain/aww023},
  pmid    = {26936940},
  url     = {https://doi.org/10.1093/brain/aww023}
}

@article{castellano2011-21715678,
  author  = {Castellano, Joseph M. and Kim, Jungsu and Stewart, Floy R. and Jiang, Hong and Demattos, Ronald Bradley and Patterson, Bruce W. and Fagan, Anne M. and Morris, John C. and Mawuenyega, Kwasi G. and Cruchaga, Carlos C and Goate, Alison and Bales, Kelly R. and Paul, Steven M. and Bateman, Randall John and Holtzman, David M.},
  title   = {{Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance}},
  journal = {Science Translational Medicine},
  year    = {2011},
  doi     = {10.1126/scitranslmed.3002156},
  pmid    = {21715678},
  url     = {https://doi.org/10.1126/scitranslmed.3002156}
}

@article{doody2013-23883379,
  author  = {Doody, Rachelle Smith and Raman, Rema and Farlow, Martin Rhys and Iwatsubo, Takeshi and Vellas, Bruno J. and Joffe, Steven and Kieburtz, Karl D. and He, Feng and Sun, Xiaoying and Thomas, Ronald G. and Aisen, Paul S. S. and Siemers, Eric and Sethuraman, Gopalan and Mohs, Richard C.},
  title   = {{A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease}},
  journal = {New England Journal of Medicine},
  year    = {2013},
  doi     = {10.1056/nejmoa1210951},
  pmid    = {23883379},
  url     = {https://doi.org/10.1056/nejmoa1210951}
}

@article{ryan2013-23299110,
  author  = {Ryan, D. J. and O'Regan, N. A. and RÓ, Caoimh and Clare, J. and O'Connor, M. and Leonard, M. and McFarland, J. and Tighe, S. and others},
  title   = {{Delirium in an adult acute hospital population: predictors, prevalence and detection}},
  journal = {BMJ open},
  year    = {2013},
  doi     = {10.1136/bmjopen-2012-001772},
  pmid    = {23299110},
  url     = {https://doi.org/10.1136/bmjopen-2012-001772}
}

@article{gaugler2013-24354549,
  author  = {Gaugler, J. E. and Ascher-Svanum, H. and Roth, D. L. and Fafowora, T. and Siderowf, A. and Beach, T. G.},
  title   = {{Characteristics of patients misdiagnosed with Alzheimer's disease and their medication use: an analysis of the NACC-UDS database}},
  journal = {BMC geriatrics},
  year    = {2013},
  doi     = {10.1186/1471-2318-13-137},
  pmid    = {24354549},
  url     = {https://doi.org/10.1186/1471-2318-13-137}
}

@article{fleisher2015-25580592,
  author  = {Fleisher, A. S. and Chen, K. and Quiroz, Y. T. and Jakimovich, L. J. and Gutierrez Gomez, M. and Langois, C. M. and Langbaum, J. B. and Roontiva, A. and others},
  title   = {{Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study}},
  journal = {JAMA neurology},
  year    = {2015},
  doi     = {10.1001/jamaneurol.2014.3314},
  pmid    = {25580592},
  url     = {https://doi.org/10.1001/jamaneurol.2014.3314}
}

@article{lyketsos2011-21889116,
  author  = {Lyketsos, C. G. and Carrillo, M. C. and Ryan, J. M. and Khachaturian, A. S. and Trzepacz, P. and Amatniek, J. and Cedarbaum, J. and Brashear, R. and others},
  title   = {{Neuropsychiatric symptoms in Alzheimer's disease}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2011},
  doi     = {10.1016/j.jalz.2011.05.2410},
  pmid    = {21889116},
  url     = {https://doi.org/10.1016/j.jalz.2011.05.2410}
}

@article{wong2010-20501908,
  author  = {Wong, D. F. and Rosenberg, P. B. and Zhou, Y. and Kumar, A. and Raymont, V. and Ravert, H. T. and Dannals, R. F. and Nandi, A. and others},
  title   = {{In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)}},
  journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year    = {2010},
  doi     = {10.2967/jnumed.109.069088},
  pmid    = {20501908},
  url     = {https://doi.org/10.2967/jnumed.109.069088}
}

@article{cirrito2005-16364896,
  author  = {Cirrito, John R. and Yamada, Kelvin A. and Finn, Mary Beth and Sloviter, Robert S. and Bales, Kelly R. and May, Patrick C. and Schoepp, Darryle D. and Paul, Steven M. and Mennerick, Steven J. and Holtzman, David M.},
  title   = {{Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo}},
  journal = {Neuron},
  year    = {2005},
  doi     = {10.1016/j.neuron.2005.10.028},
  pmid    = {16364896},
  url     = {https://doi.org/10.1016/j.neuron.2005.10.028}
}

@article{quiroz2015-26121081,
  author  = {Quiroz, Y. T. and Schultz, A. P. and Chen, K. and Protas, H. D. and Brickhouse, M. and Fleisher, A. S. and Langbaum, J. B. and Thiyyagura, P. and others},
  title   = {{Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease: A Cross-Sectional Study}},
  journal = {JAMA neurology},
  year    = {2015},
  doi     = {10.1001/jamaneurol.2015.1099},
  pmid    = {26121081},
  url     = {https://doi.org/10.1001/jamaneurol.2015.1099}
}

@article{risacher2017-29070667,
  author  = {Risacher, S. L. and Anderson, W. H. and Charil, A. and Castelluccio, P. F. and Shcherbinin, S. and Saykin, A. J. and Schwarz, A. J. and {Alzheimer's Disease Neuroimaging Initiative}},
  title   = {{Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline}},
  journal = {Neurology},
  year    = {2017},
  doi     = {10.1212/wnl.0000000000004670},
  pmid    = {29070667},
  url     = {https://doi.org/10.1212/wnl.0000000000004670}
}

@article{weiner2017-27931796,
  author  = {Weiner, M. W. and Veitch, D. P. and Aisen, P. S. and Beckett, L. A. and Cairns, N. J. and Green, R. C. and Harvey, D. and Jack, C. R. and others},
  title   = {{The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2017},
  doi     = {10.1016/j.jalz.2016.10.006},
  pmid    = {27931796},
  url     = {https://doi.org/10.1016/j.jalz.2016.10.006}
}

@article{sperling2011-21784348,
  author  = {Sperling, Reisa Anne and Jack, Clifford R. and Black, Sandra E. and Frosch, Matthew P. and Greenberg, Steven Mark and Hyman, Bradley T. and Scheltens, Philip and Carrillo, María C. and Thies, William H. and Bednar, Martin M. and Black, Ronald S. and Brashear, H. Robert and Grundman, Michael and Siemers, Eric and Feldman, Howard and Schindler, Rachel J.},
  title   = {{Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup}},
  journal = {Alzheimer s \& Dementia},
  year    = {2011},
  doi     = {10.1016/j.jalz.2011.05.2351},
  pmid    = {21784348},
  url     = {https://doi.org/10.1016/j.jalz.2011.05.2351}
}

@article{collins2026-42565262,
  author  = {Collins, E. C. and Lu, M. and Beck, R. and Hendrix, J. and Hodsdon, M. E. and Hansson, O.},
  title   = {{Plasma P-tau217 for detecting amyloid clearance after donanemab in Alzheimer's disease}},
  journal = {Alzheimer's \& Dementia},
  year    = {2026},
  doi     = {10.1002/alz.71740},
  pmid    = {42565262},
  url     = {https://doi.org/10.1002/alz.71740}
}

@article{weiner2010-20451868,
  author  = {Weiner, M. W. and Aisen, P. S. and Jack, C. R. and Jagust, W. J. and Trojanowski, J. Q. and Shaw, L. and Saykin, A. J. and Morris, J. C. and others},
  title   = {{The Alzheimer's disease neuroimaging initiative: progress report and future plans}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2010},
  doi     = {10.1016/j.jalz.2010.03.007},
  pmid    = {20451868},
  url     = {https://doi.org/10.1016/j.jalz.2010.03.007}
}

@article{wang2018-30558641,
  author  = {Wang, H. and Li, Y. and Ryder, J. W. and Hole, J. T. and Ebert, P. J. and Airey, D. C. and Qian, H. R. and Logsdon, B. and others},
  title   = {{Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal model}},
  journal = {Molecular neurodegeneration},
  year    = {2018},
  doi     = {10.1186/s13024-018-0296-y},
  pmid    = {30558641},
  url     = {https://doi.org/10.1186/s13024-018-0296-y}
}

@article{mielke2018-29626426,
  author  = {Mielke, Michelle M. and Hagen, Clinton E. and Xu, Jing and Chai, Xiyun and Vemuri, Prashanthi and Lowe, Val J. and Airey, David C. and Knopman, David S. and Roberts, Rosebud O. and Machulda, Mary M. and Jack, Clifford R. and Petersen, Ronald Carl and Dage, Jeffrey L.},
  title   = {{Plasma phospho‐tau181 increases with Alzheimer's disease clinical severity and is associated with tau‐ and amyloid‐positron emission tomography}},
  journal = {Alzheimer s \& Dementia},
  year    = {2018},
  doi     = {10.1016/j.jalz.2018.02.013},
  pmid    = {29626426},
  url     = {https://doi.org/10.1016/j.jalz.2018.02.013}
}

@article{koistinaho2004-15195085,
  author  = {Koistinaho, M. and Lin, S. and Wu, X. and Esterman, M. and Koger, D. and Hanson, J. and Higgs, R. and Liu, F. and others},
  title   = {{Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides}},
  journal = {Nature medicine},
  year    = {2004},
  doi     = {10.1038/nm1058},
  pmid    = {15195085},
  url     = {https://doi.org/10.1038/nm1058}
}

@article{trojanowski2010-20451871,
  author  = {Trojanowski, J. Q. and Vandeerstichele, H. and Korecka, M. and Clark, C. M. and Aisen, P. S. and Petersen, R. C. and Blennow, K. and Soares, H. and others},
  title   = {{Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2010},
  doi     = {10.1016/j.jalz.2010.03.008},
  pmid    = {20451871},
  url     = {https://doi.org/10.1016/j.jalz.2010.03.008}
}

@article{moscoso2025-11860bf1,
  author  = {Moscoso, Alexis and Leuzy, Antoine and Raket, Lars Lau and Villemagne, Victor L. and Klein, Gregory and Tonietto, Matteo and Olafson, Emily and Baker, Suzanne L. and others},
  title   = {{External Validation of Joint Propagation Model‐Based Tau PET CenTauR units}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70856_106362},
  url     = {https://doi.org/10.1002/alz70856_106362}
}

@article{zheng2024-37837382,
  author  = {Zheng, L. and Rubinski, A. and Denecke, J. and Luan, Y. and Smith, R. and Strandberg, O. and Stomrud, E. and Ossenkoppele, R. and others},
  title   = {{Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer Disease}},
  journal = {Annals of neurology},
  year    = {2024},
  doi     = {10.1002/ana.26818},
  pmid    = {37837382},
  url     = {https://doi.org/10.1002/ana.26818}
}

@article{wahrle2008-18202749,
  author  = {Wahrle, S. E. and Jiang, H. and Parsadanian, M. and Kim, J. and Li, A. and Knoten, A. and Jain, S. and Hirsch-Reinshagen, V. and others},
  title   = {{Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease}},
  journal = {The Journal of clinical investigation},
  year    = {2008},
  doi     = {10.1172/jci33622},
  pmid    = {18202749},
  url     = {https://doi.org/10.1172/jci33622}
}

@article{portelius2010-20350302,
  author  = {Portelius, E. and Dean, R. A. and Gustavsson, M. K. and Andreasson, U. and Zetterberg, H. and Siemers, E. and Blennow, K.},
  title   = {{A novel Abeta isoform pattern in CSF reflects gamma-secretase inhibition in Alzheimer disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2010},
  doi     = {10.1186/alzrt30},
  pmid    = {20350302},
  url     = {https://doi.org/10.1186/alzrt30}
}

@article{gold2018-29955666,
  author  = {Gold, M. and Amatniek, J. and Carrillo, M. C. and Cedarbaum, J. M. and Hendrix, J. A. and Miller, B. B. and Robillard, J. M. and Rice, J. J. and others},
  title   = {{Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trials}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2018},
  doi     = {10.1016/j.trci.2018.04.003},
  pmid    = {29955666},
  url     = {https://doi.org/10.1016/j.trci.2018.04.003}
}

@article{moscoso2025-41434902,
  author  = {Moscoso, Alexis and Leuzy, Antoine and Raket, Lars Lau and Villemagne, Victor L. and Klein, Gregory and Tonietto, Matteo and Olafson, Emily and Baker, Suzanne L. and others},
  title   = {{External Validation of Joint Propagation Model‐Based Tau PET CenTauR units}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70862_109722},
  pmid    = {41434902},
  url     = {https://doi.org/10.1002/alz70862_109722}
}

@article{bales1997-9354781,
  author  = {Bales, Kelly R. and Verina, Tatyana and Dodel, Richard C. and Du, Yansheng and Altstiel, Larry D. and Bender, Mark H. and Hyslop, Paul A. and Johnstone, Edward M. and Little, Sheila P. and Cummins, David J. and Piccardo, Pedro and Ghetti, Bernardino Francesco and Paul, Steven M.},
  title   = {{Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition}},
  journal = {Nature Genetics},
  year    = {1997},
  doi     = {10.1038/ng1197-263},
  pmid    = {9354781},
  url     = {https://doi.org/10.1038/ng1197-263}
}

@article{beyrer2026-41926844,
  author  = {Beyrer, J. and Sheff, Z. and Payakachat, N. and Chandler, J. M. and Chen, Y. F. and Kubisiak, J. and Lee, A. and Holdridge, K. C. and Yaari, R. and Aisen, P. and Rafii, M. S. and Sperling, R. A. and others},
  title   = {{Increase in healthcare utilization and Medicare payment with progression of preclinical Alzheimer's disease}},
  journal = {Journal of Prevention of Alzheimer's Disease},
  year    = {2026},
  doi     = {10.1016/j.tjpad.2026.100547},
  pmid    = {41926844},
  url     = {https://doi.org/10.1016/j.tjpad.2026.100547}
}

@article{colonna2016-26911435,
  author  = {Colonna, M. and Wang, Y.},
  title   = {{TREM2 variants: new keys to decipher Alzheimer disease pathogenesis}},
  journal = {Nature reviews. Neuroscience},
  year    = {2016},
  doi     = {10.1038/nrn.2016.7},
  pmid    = {26911435},
  url     = {https://doi.org/10.1038/nrn.2016.7}
}

@article{varatharajah2019-30783207,
  author  = {Varatharajah, Y. and Ramanan, V. K. and Iyer, R. and Vemuri, P. and {Alzheimer’s Disease Neuroimaging Initiative}},
  title   = {{Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics}},
  journal = {Scientific reports},
  year    = {2019},
  doi     = {10.1038/s41598-019-38793-3},
  pmid    = {30783207},
  url     = {https://doi.org/10.1038/s41598-019-38793-3}
}

@article{wahrle2005-16207708,
  author  = {Wahrle, S. E. and Jiang, H. and Parsadanian, M. and Hartman, R. E. and Bales, K. R. and Paul, S. M. and Holtzman, D. M.},
  title   = {{Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease}},
  journal = {The Journal of biological chemistry},
  year    = {2005},
  doi     = {10.1074/jbc.m508780200},
  pmid    = {16207708},
  url     = {https://doi.org/10.1074/jbc.m508780200}
}

@article{brendza2005-15668737,
  author  = {Brendza, R. P. and Bacskai, B. J. and Cirrito, JR. and Simmons, K. A. and Skoch, J. M. and Klunk, W. E. and Mathis, C. A. and Bales, K. R. and others},
  title   = {{Anti-Abeta antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice}},
  journal = {The Journal of clinical investigation},
  year    = {2005},
  doi     = {10.1172/jci23269},
  pmid    = {15668737},
  url     = {https://doi.org/10.1172/jci23269}
}

@article{chandler2021-33720850,
  author  = {Chandler, Julie M. and Nair, Radhika and Biglan, Kevin and Ferries, Erin A. and Munsie, Leanne M. and Changamire, Tich and Patel, Nick C.},
  title   = {{Characteristics of Parkinson’s Disease in Patients with and without Cognitive Impairment}},
  journal = {Journal of Parkinson s Disease},
  year    = {2021},
  doi     = {10.3233/jpd-202190},
  pmid    = {33720850},
  url     = {https://doi.org/10.3233/jpd-202190}
}

@article{boxer2020-31668596,
  author  = {Boxer, A. L. and Gold, M. and Feldman, H. and Boeve, B. F. and Dickinson, S. L. and Fillit, H. and Ho, C. and Paul, R. and others},
  title   = {{New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2020},
  doi     = {10.1016/j.jalz.2019.06.4956},
  pmid    = {31668596},
  url     = {https://doi.org/10.1016/j.jalz.2019.06.4956}
}

@article{schroeder2024-39539059,
  author  = {Schroeder, Krista and Afonso, Ana Sofía and Wang, Huabo and Grace, Sarah and Phipps, Adam and Sims, John Randall},
  title   = {{Demographics, comorbidities, and comedications in newly diagnosed patients with Alzheimer's disease and related dementias: Findings from United States Medicare claims data}},
  journal = {Journal of Alzheimer s Disease},
  year    = {2024},
  doi     = {10.3233/jad-231488},
  pmid    = {39539059},
  url     = {https://doi.org/10.3233/jad-231488}
}

@article{zimmer2025-41330788,
  author  = {Zimmer, Jennifer A. and Sims, John R. and Evans, Cynthia Duggan and Nery, Emel Serap Monkul and Wang, Hong and Wessels, Alette M. and Tronchin, Giulia and Sato, Shoichiro and others},
  title   = {{Donanemab in early symptomatic Alzheimer’s disease: results from the TRAILBLAZER-ALZ 2 long-term extension}},
  journal = {The Journal of Prevention of Alzheimer s Disease},
  year    = {2025},
  doi     = {10.1016/j.tjpad.2025.100446},
  pmid    = {41330788},
  url     = {https://doi.org/10.1016/j.tjpad.2025.100446}
}

@article{fryer2005-15888448,
  author  = {Fryer, J. D. and Demattos, R. B. and McCormick, L. M. and O'Dell, M. A. and Spinner, M. L. and Bales, K. R. and Paul, S. M. and Sullivan, P. M. and others},
  title   = {{The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP mice}},
  journal = {The Journal of biological chemistry},
  year    = {2005},
  doi     = {10.1074/jbc.m502143200},
  pmid    = {15888448},
  url     = {https://doi.org/10.1074/jbc.m502143200}
}

@article{shcherbinin2016-27151986,
  author  = {Shcherbinin, S. and Schwarz, A. J. and Joshi, A. and Navitsky, M. and Flitter, M. and Shankle, W. R. and Devous, M. D. and Mintun, M. A.},
  title   = {{Kinetics of the Tau PET Tracer 18F-AV-1451 (T807) in Subjects with Normal Cognitive Function, Mild Cognitive Impairment, and Alzheimer Disease}},
  journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year    = {2016},
  doi     = {10.2967/jnumed.115.170027},
  pmid    = {27151986},
  url     = {https://doi.org/10.2967/jnumed.115.170027}
}

@article{haro2014-25226106,
  author  = {Haro, J. M. and Kahle-Wrobleski, K. and Bruno, G. and Belger, M. and Dell'Agnello, G. and Dodel, R. and Jones, R. W. and Reed, C. C. and others},
  title   = {{Analysis of burden in caregivers of people with Alzheimer's disease using self-report and supervision hours}},
  journal = {The journal of nutrition, health \& aging},
  year    = {2014},
  doi     = {10.1007/s12603-014-0500-x},
  pmid    = {25226106},
  url     = {https://doi.org/10.1007/s12603-014-0500-x}
}

@article{du2001-11552007,
  author  = {Du, Y. and Dodel, R. and Hampel, H. and Buerger, K. and Lin, S. and Eastwood, B. and Bales, K. and Gao, F. and others},
  title   = {{Reduced levels of amyloid beta-peptide antibody in Alzheimer disease}},
  journal = {Neurology},
  year    = {2001},
  doi     = {10.1212/wnl.57.5.801},
  pmid    = {11552007},
  url     = {https://doi.org/10.1212/wnl.57.5.801}
}

@article{tunali2025-40081955,
  author  = {Tunali, Ilke and Wang, Jian and Arora, Anupa and Kim, Min Jung and Shcherbinin, Sergey and Pontecorvo, Michael J. and Iaccarino, Leonardo},
  title   = {{Development and Validation of a 18 F-Flortaucipir PET Visual Stratification Method}},
  journal = {Journal of Nuclear Medicine},
  year    = {2025},
  doi     = {10.2967/jnumed.124.268700},
  pmid    = {40081955},
  url     = {https://doi.org/10.2967/jnumed.124.268700}
}

@article{trzepacz2013-23602309,
  author  = {Trzepacz, P. T. and Saykin, A. and Yu, P. and Bhamditipati, P. and Sun, J. and Dennehy, E. B. and Willis, B. and Cummings, J. L. and others},
  title   = {{Subscale validation of the neuropsychiatric inventory questionnaire: comparison of Alzheimer's disease neuroimaging initiative and national Alzheimer's coordinating center cohorts}},
  journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry},
  year    = {2013},
  doi     = {10.1016/j.jagp.2012.10.027},
  pmid    = {23602309},
  url     = {https://doi.org/10.1016/j.jagp.2012.10.027}
}

@article{zerbinatti2006-17012232,
  author  = {Zerbinatti, C. V. and Wahrle, S. E. and Kim, H. and Cam, J. A. and Bales, K. and Paul, S. M. and Holtzman, D. M. and Bu, G.},
  title   = {{Apolipoprotein E and low density lipoprotein receptor-related protein facilitate intraneuronal Abeta42 accumulation in amyloid model mice}},
  journal = {The Journal of biological chemistry},
  year    = {2006},
  doi     = {10.1074/jbc.m604436200},
  pmid    = {17012232},
  url     = {https://doi.org/10.1074/jbc.m604436200}
}

@article{yim2025-40910876,
  author  = {Yim, S. and Gu, Y. and Kang, H. and Shin, D. and Jang, H. and Yoo, H. and Zetterberg, H. and Blennow, K. and others},
  title   = {{Prognostic Value of A/T/N Biomarkers: Comparing Plasma and Imaging Modalities in Alzheimer Disease}},
  journal = {Clinical nuclear medicine},
  year    = {2025},
  doi     = {10.1097/rlu.0000000000006088},
  pmid    = {40910876},
  url     = {https://doi.org/10.1097/rlu.0000000000006088}
}

@article{cavallini2013-23798682,
  author  = {Cavallini, A. and Brewerton, S. and Bell, A. and Sargent, S. and Glover, S. and Hardy, C. and Moore, R. and Calley, J. and others},
  title   = {{An unbiased approach to identifying tau kinases that phosphorylate tau at sites associated with Alzheimer disease}},
  journal = {The Journal of biological chemistry},
  year    = {2013},
  doi     = {10.1074/jbc.m113.463984},
  pmid    = {23798682},
  url     = {https://doi.org/10.1074/jbc.m113.463984}
}

@article{abel2025-39836199,
  author  = {Abel, A. and Chambers, A. and Fill, J. and Reiske, H. and Lu, M. and Morris, A. and Faya, P. and Beck, R. C. and others},
  title   = {{Analytical Validation and Performance of a Blood-Based P-tau217 Diagnostic Test for Alzheimer Disease}},
  journal = {The journal of applied laboratory medicine},
  year    = {2025},
  doi     = {10.1093/jalm/jfae155},
  pmid    = {39836199},
  url     = {https://doi.org/10.1093/jalm/jfae155}
}

@article{gitter1995-7479875,
  author  = {Gitter, B. D. and Cox, L. M. and Rydel, R. E. and May, P. C.},
  title   = {{Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells}},
  journal = {Proceedings of the National Academy of Sciences of the United States of America},
  year    = {1995},
  doi     = {10.1073/pnas.92.23.10738},
  pmid    = {7479875},
  url     = {https://doi.org/10.1073/pnas.92.23.10738}
}

@article{bales2002-14993413,
  author  = {Bales, K. R. and Dodart, J. C. and DeMattos, R. B. and Holtzman, D. M. and Paul, S. M.},
  title   = {{Apolipoprotein E, amyloid, and Alzheimer disease}},
  journal = {Molecular interventions},
  year    = {2002},
  doi     = {10.1124/mi.2.6.363},
  pmid    = {14993413},
  url     = {https://doi.org/10.1124/mi.2.6.363}
}

@article{hsu2025-40887393,
  author  = {Hsu, Jung‐Lung and Park, Kee Hyung and Panegyres, Peter K. and Huang, Yao Hsien and Eom, Young In and Prusty, Vinay and Tan, Lolita Stephanie and Shea, Yat Fung},
  title   = {{Early Alzheimer’s disease (mild cognitive impairment or mild dementia): Prevalence, diagnostics, treatment options, and guidelines in Asia, Australasia, and Pacific nations countries}},
  journal = {The Journal of Prevention of Alzheimer s Disease},
  year    = {2025},
  doi     = {10.1016/j.tjpad.2025.100362},
  pmid    = {40887393},
  url     = {https://doi.org/10.1016/j.tjpad.2025.100362}
}

@article{schroeder2023-3c0c71b6,
  author  = {Schroeder, Krista Marie and Afonso, Ana Sofía and Wang, Huabo and Grace, Sarah and Phipps, Adam and Sims, John Randall},
  title   = {{Characterize demographics, comorbidities and co‐medications in newly diagnosed United States (US) Alzheimer’s Disease patients using Medicare claims}},
  journal = {Alzheimer s \& Dementia},
  year    = {2023},
  doi     = {10.1002/alz.073825},
  url     = {https://doi.org/10.1002/alz.073825}
}

@article{afonso2023-bd017ecc,
  author  = {Afonso, Ana Sofía and Schroeder, Krista Marie and Wang, Huabo and Grace, Sarah and Phipps, Adam and Sims, John Randall},
  title   = {{Using a newly validated algorithm to estimate prevalence and incidence of Alzheimer’s Disease and related dementias in Medicare claims}},
  journal = {Alzheimer s \& Dementia},
  year    = {2023},
  doi     = {10.1002/alz.073664},
  url     = {https://doi.org/10.1002/alz.073664}
}

@article{spargo2025-41433569,
  author  = {Spargo, D. J. and Anaya, Pablo and Krishnamurthy, Pallavi and Sapin, Christophe and Hendrix, James A. and Burnham, Samantha C. and Beck, Rose C},
  title   = {{The economic value of plasma p ‐tau217 testing for patients presenting with cognitive impairment in the United States}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70861_108060},
  pmid    = {41433569},
  url     = {https://doi.org/10.1002/alz70861_108060}
}